SCHEMBL7572487

SCHEMBL7572487

C=CC(O)N1CCc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.46
SLC6A4 P31645 4/20 0.46
SIGMAR1 Q99720 2/20 0.43
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
CDK4 P11802 1/20 0.42
ALOX15 P16050 1/20 0.42
CCND1 P24385 1/20 0.42
NOTUM Q6P988 1/20 0.41
TSHR P16473 2/20 0.40
TP53 P04637 2/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9636499 0.90 SMN1; SMN2 (0.46) SIGMAR1ALDH1A1MEN1KMT2ANOTUM
SCHEMBL463221 0.79 SLC6A2 (0.42) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL28763194 0.79 MEN1 (0.42) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL6262183 0.77 SLC6A2 (0.52) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL25112007 0.77 SLC6A2 (0.49) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL28241893 0.76 ALDH1A1 (0.39) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL21255141 0.73 SLC6A2 (0.41) SLC6A2SLC6A4ALDH1A1MEN1KMT2A
SCHEMBL13066479 0.73 ALDH1A1 (0.50) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL10434906 0.72 SLC6A2 (0.52) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1
SCHEMBL14110030 0.72 ALDH1A1 (0.48) SLC6A2SLC6A4SIGMAR1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888349-B1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2002-05-22 EP disclosed
US-6140317-A AS INHIBITORS OF PROTEIN KINASES AND HAVE ANTITUMOUR ACTIVITY NOVARTIS AG (CH) 2000-10-31 US disclosed
US-5736534-A HYPERPROLIFERATIVE DISEASES; INHIBITORS OF PROTEIN-TYROSINE KINASES SUCH AS EPIDERMAL GROWTH FACTOR RECEPTOR; BRAIN, LUNG, BREAST CANCER; PSORIASIS AND BENIGN PROSTATE HYPERPLASIA PFIZER INC. (US) 1998-04-07 US disclosed
CN-1141633-A 4-heterocyclic substituted quinazoline derivatives, process for their preparation and their use as anticancer agents PFIZER (US) 1997-01-29 CN disclosed
EP-0746554-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1996-12-11 EP disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed